Effects of Erythropoietin Payment Policy on Cardiovascular Outcomes of Peritoneal Dialysis Patients: Observational Study.

Ying-Hui Hou Feng-Jung Yang I-Chun Lai Shih-Pi Lin Thomas T H Wan Ray-E Chang

Published in: JMIR medical informatics (2020)

After loosening erythropoietin payment criteria, reduced cardiovascular risks were observed, particularly for patients with diabetes. These results indicate that it is crucial to maintain an Hct level above 30% to reduce the cardiovascular risk in patients with diabetes undergoing peritoneal dialysis.

Keyphrases

peritoneal dialysis
end stage renal disease
chronic kidney disease
healthcare
public health
health insurance
recombinant human
ejection fraction
risk assessment
cell death
affordable care act
climate change
patient reported outcomes